72 related articles for article (PubMed ID: 15680177)
21. Acute and chronic cocaine behavioral effects in novel versus familiar environments: open-field familiarity differentiates cocaine locomotor stimulant effects from cocaine emotional behavioral effects.
Carey RJ; DePalma G; Damianopoulos E
Behav Brain Res; 2005 Mar; 158(2):321-30. PubMed ID: 15698899
[TBL] [Abstract][Full Text] [Related]
22. Cocaine self-administration and locomotor sensitization are not altered in CART knockout mice.
Steiner RC; Hsiung HM; Picciotto MR
Behav Brain Res; 2006 Jul; 171(1):56-62. PubMed ID: 16621045
[TBL] [Abstract][Full Text] [Related]
23. Automated discrimination of psychotropic drugs in mice via computer vision-based analysis.
Yucel Z; Sara Y; Duygulu P; Onur R; Esen E; Ozguler AB
J Neurosci Methods; 2009 Jun; 180(2):234-42. PubMed ID: 19464515
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment.
McNamara RK; Sullivan J; Richtand NM
J Psychiatr Res; 2008 May; 42(6):458-68. PubMed ID: 17628596
[TBL] [Abstract][Full Text] [Related]
25. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
26. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
Russig H; Pryce CR; Feldon J
Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
[TBL] [Abstract][Full Text] [Related]
28. Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences.
Võikar V; Polus A; Vasar E; Rauvala H
Genes Brain Behav; 2005 Jun; 4(4):240-52. PubMed ID: 15924556
[TBL] [Abstract][Full Text] [Related]
29. Behavioral, physiological, and molecular differences in response to dietary restriction in three inbred mouse strains.
Gelegen C; Collier DA; Campbell IC; Oppelaar H; Kas MJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E574-81. PubMed ID: 16670152
[TBL] [Abstract][Full Text] [Related]
30. Repeated amphetamine treatment increases phosphorylation of extracellular signal-regulated kinase, protein kinase B, and cyclase response element-binding protein in the rat striatum.
Shi X; McGinty JF
J Neurochem; 2007 Oct; 103(2):706-13. PubMed ID: 17635666
[TBL] [Abstract][Full Text] [Related]
31. The relationship between the locomotor response to a novel environment and behavioral disinhibition in rats.
Stoffel EC; Cunningham KA
Drug Alcohol Depend; 2008 Jan; 92(1-3):69-78. PubMed ID: 17997051
[TBL] [Abstract][Full Text] [Related]
32. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
33. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
Celik E; Uzbay IT; Karakas S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
[TBL] [Abstract][Full Text] [Related]
34. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
Ishizuka T; Murakami M; Yamatodani A
Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
[TBL] [Abstract][Full Text] [Related]
35. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice.
Yin HS; Chen K; Kalpana S; Shih JC
Synapse; 2006 Dec; 60(8):573-84. PubMed ID: 16983645
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam.
Castro AA; Moretti M; Casagrande TS; Martinello C; Petronilho F; Steckert AV; Guerrini R; Calo' G; Dal Pizzol F; Quevedo J; Gavioli EC
Pharmacol Biochem Behav; 2009 Feb; 91(4):636-42. PubMed ID: 19022279
[TBL] [Abstract][Full Text] [Related]
38. Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure.
Frey BN; Andreazza AC; Ceresér KM; Martins MR; Petronilho FC; de Souza DF; Tramontina F; Gonçalves CA; Quevedo J; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1231-4. PubMed ID: 16631293
[TBL] [Abstract][Full Text] [Related]
39. The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
Häggkvist J; Lindholm S; Franck J
Addict Biol; 2009 Jul; 14(3):260-9. PubMed ID: 19298318
[TBL] [Abstract][Full Text] [Related]
40. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
Russig H; Murphy CA; Feldon J
Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
